The effect of fennel (Foeniculum Vulgar) oral capsules on quality of life and sexual function in postmenopausal women: Triple blind randomized clinical trial

Not Applicable

Conditions: Menopausal and female climacteric states
Condition 1: quality of life in postmenopausal women. Condition 2: sexual function in postmenopausal women.
Unspecified sexual dyfunction, not caused by organic disorder or disease

Registration Number: IRCT2016081927788N3

Lead Sponsor: Vice chancellor for research, Tehran University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: Female

Target Recruitment: 90

Inclusion Criteria

women aged between 45-60 years; married women; women in the first 1-5 years of their post menopausal period; women with at least a sexual relationship per month; Negative history of physical and psychological diseases; Negative history of breast cancer; Negative history of hormone therapy and complementary medicine for menopausel symptoms; Negative history of Allergy to herbal medicine; Negative history of sedative and anti depressant drugs usage; Negative history of addiction and smoking; women with at least the ability to read and write. exclusion criteria: allergy to foeniculum vulgare during the intervention; worsening the disease during the intervention; poor cooperation during the intervention; stop using foeniculum vulgare/placebo for at least 6 days; using of other remedies for menopausal symptoms during the study; women without at least a sexual relationship per month during the intervention.

Exclusion Criteria

Not provided

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sexual function in postmenopause women. Timepoint: before intervention and at 4th and 8th week of the intervention. Method of measurement: sabbatsberg questionnaire (for sexual function in postmenopausal women).;Quality of life in postmenopause women. Timepoint: before intervention and at 4th and 8th week of the intervention. Method of measurement: Menopause quality of life questionnaire (MENQOL).

Secondary Outcome Measures